サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1774822

体外式膜酸素化カニューレの世界市場

Extracorporeal Membrane Oxygenation Cannula

出版日
ページ情報
英文 463 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.39円
体外式膜酸素化カニューレの世界市場
出版日: 2025年07月23日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 463 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

体外式膜酸素化カニューレの世界市場は2030年までに3,920万米ドルに達する見込み

2024年に3,270万米ドルと推定される体外式膜酸素化カニューレの世界市場は、分析期間2024-2030年にCAGR 3.0%で成長し、2030年には3,920万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである静脈-動脈は、CAGR 2.2％を記録し、分析期間終了時には1,950万米ドルに達すると予測されます。血管-静脈セグメントの成長率は、分析期間でCAGR 4.1%と推定されます。

米国市場は890万米ドルと推定され、中国はCAGR 5.6％で成長すると予測される

米国の体外式膜酸素化カニューレ市場は2024年に890万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに760万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.2％と2.3％と予測されています。欧州では、ドイツがCAGR 1.7%で成長すると予測されています。

体外式膜酸素療法（ECMO）カニューレの世界市場- 主要動向と促進要因まとめ

ECMOカニューレとは何か、なぜ生命維持に不可欠なのか？

体外式膜酸素療法（ECMO）カニューレは、重度の心不全や呼吸不全に陥った患者のための高度な生命維持療法であるECMO療法で使用される特殊な医療機器です。これらのカニューレは、体外に血液を循環させる主要な導管として機能し、心臓や肺が十分に機能しない場合に酸素補給と二酸化炭素除去を可能にします。ECMO療法は、特に急性呼吸窮迫症候群（ARDS）、心原性ショック、心臓手術後の回復など、クリティカルケアにおいて広く利用されています。呼吸器疾患、心臓疾患、およびCOVID-19に見られるようなパンデミック関連の合併症の発生率が増加しているため、世界中の集中治療室（ICU）でECMOカニューレの需要が高まっています。

ECMOカニューレの設計と機能性は、患者の転帰に決定的な役割を果たします。これらのカニューレは、最適な血流、溶血の減少、血管系への外傷の最小化を目指して設計されています。その構成は、採用するECMO療法の種類（呼吸補助のための動静脈（VV）ECMO、心肺補助のための静脈動脈（VA）ECMO）によって異なります。ECMOカニューレの進化は、生体適合性、耐久性、挿入の容易さを向上させ、血栓形成、感染リスク、患者の快適性に関する課題に対処してきました。

ECMOカニューレの設計における技術革新は、患者の転帰をどのように改善しているか？

ECMOカニューレの設計における技術的進歩は、患者の安全性、効率、使いやすさを大幅に改善しました。最も注目すべき開発のひとつは、ヘパリンコートおよび抗菌カニューレの導入であり、長期ECMO療法に関連する2つの主要合併症である凝固および感染のリスクを低減しています。さらに、柔軟性のあるワイヤー補強カニューレの使用により耐久性が向上し、挿入時および長期使用時の血管の外傷が最小限に抑えられました。

もう1つの重要な技術革新は、経皮的挿入技術を取り入れたことです。この技術により、侵襲が少なく短時間でカニューレを挿入できるようになり、開腹手術の必要性が減少しました。さらに、センサー一体型カニューレの進歩により、流量動態と酸素化レベルをリアルタイムでモニターできるようになり、臨床医が正確な調整を行い、ECMO管理全体を改善するのに役立っています。こうした開発は、重症患者における体外生命維持の有効性を高めつつ、ECMO関連の合併症を減らすことに重点を置きつつあることと一致しています。

ECMOカニューレ市場の成長を促進している要因は何か？

心血管系および呼吸器系疾患の有病率の増加、重篤な疾患によるICU入室の増加などが、ECMOカニューレの需要を促進しています。心不全、敗血症、慢性閉塞性肺疾患（COPD）などの疾患がECMO療法への依存度を高め、カニューレ技術の進歩が必要とされています。COVID-19の大流行も、重症呼吸不全の管理におけるECMOの重要性を浮き彫りにし、ECMOインフラと機器への投資を促しました。

ECMOカニューレ市場の成長は、急性呼吸器疾患の罹患率の上昇、クリティカルケアにおけるECMO療法の採用増加、カニューレの材料や設計における継続的な技術進歩など、いくつかの要因によってもたらされます。新興市場におけるヘルスケア・インフラの拡大は、より多くの病院や心臓専門センターがECMOを標準的な生命維持手段として採用していることから、需要をさらに促進しています。さらに、生体工学的カニューレや統合モニタリング・システムの研究が進んでおり、ECMOの有効性を高め、市場拡大をさらに促進すると期待されています。救命のための体外療法のニーズが高まり続ける中、ECMOカニューレ市場は、技術革新、臨床的進歩、クリティカルケア管理におけるECMOの役割の拡大が原動力となり、持続的な成長が見込まれています。

セグメント

タイプ（静脈-動脈、静脈-静脈、動脈-静脈）、患者（新生児、小児、成人）、用途（呼吸器用途、心臓用途、Ecpr用途）、最終用途（病院最終用途、外来手術センター最終用途、その他最終用途）

調査対象企業の例

  • Abbott Laboratories
  • Abiomed, Inc.
  • Andocor
  • Biometrix
  • Changzhou KangXin Medical Instruments Co., Ltd.
  • Edwards Lifesciences Corporation
  • Eurosets S.r.l.
  • Free Life Medical GmbH
  • Fresenius Medical Care AG
  • Getinge AB
  • LivaNova PLC
  • Maquet（a Getinge Group Company）
  • MC3 Cardiopulmonary
  • Medtronic
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Novalung GmbH（a Fresenius Medical Care Company）
  • Sorin Group（now part of LivaNova）
  • Terumo Corporation
  • Xenios AG（a Fresenius Medical Care Company）

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP30872

Global Extracorporeal Membrane Oxygenation Cannula Market to Reach US$39.2 Million by 2030

The global market for Extracorporeal Membrane Oxygenation Cannula estimated at US$32.7 Million in the year 2024, is expected to reach US$39.2 Million by 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Veno-Arterial, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$19.5 Million by the end of the analysis period. Growth in the Veno-Venous segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.9 Million While China is Forecast to Grow at 5.6% CAGR

The Extracorporeal Membrane Oxygenation Cannula market in the U.S. is estimated at US$8.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.6 Million by the year 2030 trailing a CAGR of 5.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Extracorporeal Membrane Oxygenation (ECMO) Cannula Market - Key Trends & Drivers Summarized

What Are ECMO Cannulas and Why Are They Critical in Life Support?

Extracorporeal Membrane Oxygenation (ECMO) cannulas are specialized medical devices used in ECMO therapy, a form of advanced life support for patients experiencing severe cardiac and respiratory failure. These cannulas serve as the primary conduit for blood circulation outside the body, allowing for oxygenation and carbon dioxide removal in cases where the heart and lungs cannot function adequately. ECMO therapy is widely utilized in critical care, particularly in cases of acute respiratory distress syndrome (ARDS), cardiogenic shock, and post-cardiac surgery recovery. The increasing incidence of respiratory illnesses, cardiac disorders, and pandemic-related complications, such as those seen in COVID-19, has heightened the demand for ECMO cannulas in intensive care units (ICUs) worldwide.

The design and functionality of ECMO cannulas play a crucial role in patient outcomes. These cannulas are engineered for optimal blood flow, reduced hemolysis, and minimized trauma to the vascular system. Their configuration varies based on the type of ECMO therapy employed-venovenous (VV) ECMO for respiratory support and venoarterial (VA) ECMO for both cardiac and pulmonary assistance. The evolution of ECMO cannulas has led to improvements in biocompatibility, durability, and ease of insertion, addressing challenges related to clot formation, infection risks, and patient comfort.

How Are Innovations in ECMO Cannula Design Improving Patient Outcomes?

Technological advancements in ECMO cannula design have significantly improved patient safety, efficiency, and ease of use. One of the most notable developments is the introduction of heparin-coated and antimicrobial cannulas, which reduce the risk of clotting and infection-two major complications associated with prolonged ECMO therapy. Additionally, the use of flexible, wire-reinforced cannulas has enhanced their durability and minimized vessel trauma during insertion and prolonged use.

Another key innovation is the incorporation of percutaneous insertion techniques, which allow for a less invasive and quicker cannulation process, reducing the need for open surgery. Furthermore, advancements in sensor-integrated cannulas are emerging, enabling real-time monitoring of flow dynamics and oxygenation levels, which helps clinicians make precise adjustments and improve overall ECMO management. These developments align with the growing emphasis on reducing ECMO-related complications while enhancing the effectiveness of extracorporeal life support in critically ill patients.

What Factors Are Fueling the Growth of the ECMO Cannula Market?

The increasing prevalence of cardiovascular and respiratory disorders, coupled with rising ICU admissions for critical illnesses, is driving demand for ECMO cannulas. Conditions such as heart failure, sepsis, and chronic obstructive pulmonary disease (COPD) have led to a higher reliance on ECMO therapy, necessitating advancements in cannula technology. The COVID-19 pandemic also underscored the importance of ECMO in managing severe respiratory failure, prompting investments in ECMO infrastructure and equipment.

The growth in the ECMO cannula market is driven by several factors, including the rising incidence of acute respiratory conditions, increasing adoption of ECMO therapy in critical care, and continuous technological advancements in cannula materials and design. Expanding healthcare infrastructure in emerging markets is further fueling demand, as more hospitals and specialized cardiac centers adopt ECMO as a standard life-support measure. Moreover, ongoing research into bioengineered cannulas and integrated monitoring systems is expected to enhance ECMO efficacy, further propelling market expansion. As the need for life-saving extracorporeal therapies continues to rise, the ECMO cannula market is poised for sustained growth, driven by innovation, clinical advancements, and the expanding role of ECMO in critical care management.

SCOPE OF STUDY:

The report analyzes the Extracorporeal Membrane Oxygenation Cannula market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Veno-Arterial, Veno-Venous, Arterio-Venous); Patient (Neonates, Pediatric, Adult); Application (Respiratory Application, Cardiac Application, Ecpr Application); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • Andocor
  • Biometrix
  • Changzhou KangXin Medical Instruments Co., Ltd.
  • Edwards Lifesciences Corporation
  • Eurosets S.r.l.
  • Free Life Medical GmbH
  • Fresenius Medical Care AG
  • Getinge AB
  • LivaNova PLC
  • Maquet (a Getinge Group Company)
  • MC3 Cardiopulmonary
  • Medtronic
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Novalung GmbH (a Fresenius Medical Care Company)
  • Sorin Group (now part of LivaNova)
  • Terumo Corporation
  • Xenios AG (a Fresenius Medical Care Company)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Extracorporeal Membrane Oxygenation Cannula - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Respiratory and Cardiac Failure Cases Drives Demand for ECMO Cannulation Systems
    • Surge in ECMO Use During COVID-19 Pandemic Throws the Spotlight on Veno-Venous and Veno-Arterial Configurations
    • Expansion of ECMO Centers in Tertiary and Cardiac Hospitals Strengthens Business Case for Cannula Upgrades
    • Technological Advancements in Dual-Lumen and Bi-Caval Cannula Designs Enhance Flow Efficiency and Patient Outcomes
    • Growth in Adult and Pediatric ECMO Applications Supports Demand for Age-Specific Cannula Options
    • Use in Bridge-to-Lung and Bridge-to-Heart Transplantation Expands Critical Care Utility
    • Development of Heparin-Coated and Biocompatible Cannulas Minimizes Thrombosis and Hemolysis Risks
    • Increased Use of Percutaneous Insertion Techniques Enhances Minimally Invasive Cannulation
    • Expansion of Mobile ECMO Transport Units Promotes Use of Portable, Easy-to-Secure Cannulas
    • Availability of Imaging-Compatible Cannula Tip Designs Enhances Fluoroscopy and Ultrasound Guidance
    • Increased Demand for Emergency Cannulation in Refractory Cardiac Arrest Supports ECPR Adoption
    • Rising Need for Long-Term ECMO Support Promotes Durable, Low-Resistance Cannula Materials
    • Use in Neonatal and Congenital Heart Surgery Patients Expands Low-Profile Cannula Development
    • Growth of Hybrid ORs and Cath Labs With ECMO Capabilities Enhances System Integration
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Extracorporeal Membrane Oxygenation Cannula Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Extracorporeal Membrane Oxygenation Cannula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Veno-Arterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Veno-Arterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Veno-Arterial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Veno-Venous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Veno-Venous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Veno-Venous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Arterio-Venous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Arterio-Venous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Arterio-Venous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Neonates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Neonates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Neonates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Pediatric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Adult by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Respiratory Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Respiratory Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Respiratory Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Cardiac Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Cardiac Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Cardiac Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Ecpr Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Ecpr Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Ecpr Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Extracorporeal Membrane Oxygenation Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • JAPAN
    • Extracorporeal Membrane Oxygenation Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • CHINA
    • Extracorporeal Membrane Oxygenation Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • EUROPE
    • Extracorporeal Membrane Oxygenation Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Extracorporeal Membrane Oxygenation Cannula by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • FRANCE
    • Extracorporeal Membrane Oxygenation Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 104: France Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • GERMANY
    • Extracorporeal Membrane Oxygenation Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Extracorporeal Membrane Oxygenation Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 140: UK Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Spain 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Spain 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Russia 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Russia 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Extracorporeal Membrane Oxygenation Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation Cannula by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Extracorporeal Membrane Oxygenation Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Australia 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Australia 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • INDIA
    • Extracorporeal Membrane Oxygenation Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 215: India Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: India 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 224: India Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: India Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: India 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: South Korea 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: South Korea 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Extracorporeal Membrane Oxygenation Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Extracorporeal Membrane Oxygenation Cannula by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Argentina 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Argentina 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: Brazil 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: Brazil 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Mexico 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Mexico 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Extracorporeal Membrane Oxygenation Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Extracorporeal Membrane Oxygenation Cannula by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 328: Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 337: Iran 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 340: Iran 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 349: Israel 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 352: Israel 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 364: Saudi Arabia 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 373: UAE 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 375: UAE Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 376: UAE 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 388: Rest of Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030
  • AFRICA
    • Extracorporeal Membrane Oxygenation Cannula Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Extracorporeal Membrane Oxygenation Cannula by Type - Veno-Arterial, Veno-Venous and Arterio-Venous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Type - Percentage Breakdown of Value Sales for Veno-Arterial, Veno-Venous and Arterio-Venous for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Extracorporeal Membrane Oxygenation Cannula by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for Extracorporeal Membrane Oxygenation Cannula by Patient - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 397: Africa 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Patient - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Africa Historic Review for Extracorporeal Membrane Oxygenation Cannula by Application - Respiratory Application, Cardiac Application and Ecpr Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 400: Africa 15-Year Perspective for Extracorporeal Membrane Oxygenation Cannula by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and Ecpr Application for the Years 2015, 2025 & 2030

IV. COMPETITION